AdvaMed Praises Expanded Coverage of FDA-Designated “Breakthrough” Medical Technologies for Medicare Beneficiaries
WASHINGTON, D.C. – Today, AdvaMed President and CEO Scott Whitaker commended CMS on the rule the agency released today establishing a new coverage pathway – MCIT – for breakthrough medical technologies: